Clinical Efficacy of Anlotinib Combined with Paclitaxel and Cisplatin as First-line Treatment of Advanced Esophageal Squamous Cell Carcinoma

Clinical Efficacy of Anlotinib Combined with Paclitaxel and Cisplatin as First-line Treatment of Advanced Esophageal Squamous Cell Carcinoma

Objective To observe the efficacy and side effects of anlotinib combined with paclitaxel and cisplatin as the first-line treatment of advanced esophageal squamous cell carcinoma (ESCC). Methods We retrospectively analyzed 50 cases of advanced esophageal squamous cell carcinoma diagnosed pathological...

Full description

Bibliographic Details
Main Authors: YANG Xiaoli, WANG Cailing, XIA Jin, WANG Junsheng
Format: Article
Language:zho
Published: Magazine House of Cancer Research on Prevention and Treatment 2021-07-01
Series:Zhongliu Fangzhi Yanjiu
Subjects:
esophageal squamous cell carcinoma
anlotinib
paclitaxel
cisplatin
chemotherapy
adverse reaction
Online Access:http://html.rhhz.net/ZLFZYJ/html/8578.2021.21.0095.htm

Internet

http://html.rhhz.net/ZLFZYJ/html/8578.2021.21.0095.htm

Similar Items